+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Lung Models Market - Global Forecast 2026-2032- Product Image
Human Lung Models Market - Global Forecast 2026-2032- Product Image
Sale

Human Lung Models Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128733
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Lung Models Market is projected to reach USD 361.41 Million in 2026. It is expected to continue growing at a CAGR of 7.86%, reaching USD 564.43 Million by 2032.

Human Lung Models: Executive Summary

Human lung models are laboratory systems designed to reproduce selected aspects of pulmonary structure, function, disease biology, or drug response. The field includes organoids, tissue-engineered constructs, organ-on-chip platforms, ex vivo lung preparations, and computationally supported models. Their value lies in improving biological relevance, enabling controlled experimentation, and complementing animal studies and clinical research.

From Simplified Assays to Human-Relevant Platforms

The landscape is shifting from static, single-cell-type assays toward multicellular, dynamic, and physiologically responsive systems. Greater attention is being placed on epithelial-endothelial interactions, immune components, airflow, mechanical stretch, vascular perfusion, and patient-specific disease phenotypes. Standardized protocols, reproducible materials, validated endpoints, and interoperable data practices are increasingly important because model complexity can otherwise reduce comparability between laboratories.

Artificial Intelligence Strengthens Model Design and Interpretation

Artificial intelligence is contributing to image analysis, cellular phenotyping, experimental optimization, quality control, and interpretation of high-dimensional molecular data generated by human lung models. Machine-learning methods can help identify morphological patterns, classify disease states, and connect model outputs with pharmacological responses. Their usefulness depends on representative training data, transparent validation, appropriate controls, and careful handling of batch effects; AI should augment biological expertise rather than replace experimental confirmation.

Regional Insights Across Research and Translation Ecosystems

North America combines strong biomedical research capacity, advanced translational programs, and established regulatory engagement. Europe emphasizes collaborative infrastructure, organ-on-chip development, and harmonization across the European research environment. Asia-Pacific is supported by substantial activity in biotechnology, regenerative medicine, and precision health, with Japan, China, South Korea, Australia, and India contributing distinct capabilities. Latin America is building capacity through academic and public-health collaborations, particularly around infectious and respiratory disease. The Middle East is expanding research infrastructure and partnerships, while Africa presents important opportunities for locally relevant respiratory-disease models alongside continuing needs for equipment, training, and standardized access.

Group Insights: Collaboration Shapes Adoption

ASEAN countries are positioned to benefit from shared infrastructure, regional training, and collaborative studies addressing infectious and chronic respiratory disease. BRICS members provide a broad base of scientific, clinical, and manufacturing capabilities, although standards and access vary across institutions. The European Union supports cross-border research coordination and regulatory alignment. G7 members contribute mature biomedical ecosystems and validation expertise. GCC countries are strengthening advanced healthcare and life-science capacity through investment and international collaboration. NATO members offer extensive defense, public-health, and biomedical research networks that can support work on respiratory threats, subject to appropriate governance and data safeguards.

Country Insights: Diverse Capabilities and Priorities

Australia supports translational respiratory research and advanced biomedical collaboration; Brazil is developing applications relevant to infectious disease and public health; Canada contributes strong academic and regenerative-medicine expertise; China combines substantial research capacity with expanding biotechnology infrastructure. France, Germany, Italy, Spain, and the United Kingdom have established research institutions and coordinated European links, with activity spanning pulmonary disease, tissue engineering, and drug evaluation. India is expanding affordable and scalable biomedical innovation. Japan and South Korea are advancing precision medicine, microphysiological systems, and automated analysis. Mexico is strengthening research networks and regional collaboration. Russia retains capabilities in biomedical research but faces constraints related to international collaboration and access to some technologies. The United States remains a major center for model development, translational research, and regulatory-science activity.

Priorities for Leaders Building Reliable Human Lung Models

Industry leaders should select models according to the biological question rather than novelty alone, define validation criteria before experimentation, and compare outputs with clinically relevant reference data. Investment should prioritize reproducible protocols, qualified materials, robust controls, and shared data standards. Partnerships among model developers, pharmaceutical researchers, clinicians, regulators, and patient groups can improve relevance and adoption. Organizations should also establish governance for human-derived samples, privacy, biosafety, and AI-assisted analysis, while building scalable workflows that preserve model fidelity during routine use.

Research Methodology for the Executive Summary

This summary uses the supplied market definition-human lung models-as its analytical scope and organizes findings around technology evolution, artificial intelligence, geography, stakeholder groupings, and implementation priorities. Insights are based on established characteristics of lung-model research, including organoids, tissue-engineered systems, organ-on-chip platforms, ex vivo preparations, and computational analysis. Regional, group, and country observations are presented qualitatively and avoid unsupported estimates, rankings, market shares, forecasts, or company-specific claims. Interpretation should be supplemented with primary literature, regulatory guidance, and local validation data for investment or operational decisions.

Conclusion: Validation and Integration Will Define Progress

Human lung models are becoming more useful as they incorporate multiple human cell types, physiological forces, disease-specific features, and quantitative readouts. Progress will depend less on complexity alone than on demonstrated reproducibility, clinical relevance, transparent reporting, and compatibility with real research workflows. Organizations that combine rigorous validation with responsible AI, cross-disciplinary collaboration, and regionally appropriate implementation will be best positioned to translate these models into more informative disease studies and therapeutic-development decisions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Lung Models Market, by Model Type
7.1. Introduction
7.2. Ex Vivo
7.3. In Silico
7.4. In Vitro
7.4.1. 2D Cell Lines
7.4.2. 3D Cultures
7.4.2.1. Scaffold-Based
7.4.2.2. Scaffold-Free
7.4.3. Primary Cell Cultures
7.5. In Vivo
7.6. Organoid
8. Human Lung Models Market, by Technology
8.1. Introduction
8.2. Bioprinting
8.3. Computational Modeling
8.4. Imaging
8.4.1. Computed Tomography
8.4.2. Magnetic Resonance Imaging
8.4.3. Microscopy
8.5. Microfluidics
9. Human Lung Models Market, by Application
9.1. Introduction
9.2. Disease Modeling
9.2.1. Cancer
9.2.2. COPD
9.2.3. Fibrosis
9.2.4. Respiratory Infections
9.3. Drug Discovery
9.4. Precision Medicine
9.5. Toxicity Testing
10. Human Lung Models Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotechnology Companies
11. Human Lung Models Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Human Lung Models Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Human Lung Models Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AlveoliX Sàrl
15.2. CN Bio Innovations Limited
15.3. Emulate, Inc.
15.4. Epithelix Sàrl
15.5. Hurel Corporation
15.6. InSphero AG
15.7. MatTek Corporation
15.8. MIMETAS B.V.
15.9. Nortis, Inc.
15.10. TissUse GmbH
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Lung Models Market, Years Considered for the Study
FIGURE 2. Global Human Lung Models Market, Research Design
FIGURE 3. Global Human Lung Models Market, Research Framework
FIGURE 4. Global Human Lung Models Market, Data Triangulation
FIGURE 5. Global Human Lung Models Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Lung Models Market Size, by Model Type, 2025 vs 2032 (%)
FIGURE 7. Global Human Lung Models Market Size, by Model Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Lung Models Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Human Lung Models Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Lung Models Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Human Lung Models Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Lung Models Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Human Lung Models Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Lung Models Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Human Lung Models Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Lung Models Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Human Lung Models Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Human Lung Models Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human Lung Models Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Lung Models Market Segmentation & Coverage
TABLE 2. Global Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 4. Global Ex Vivo Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ex Vivo Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ex Vivo Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global In Silico Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global In Silico Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global In Silico Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global In Vitro Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global In Vitro Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global In Vitro Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global 2D Cell Lines Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global 2D Cell Lines Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global 2D Cell Lines Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global 3D Cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global 3D Cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global 3D Cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Scaffold-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Scaffold-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Scaffold-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Scaffold-Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Scaffold-Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Scaffold-Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Primary Cell Cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Primary Cell Cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Primary Cell Cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global In Vivo Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global In Vivo Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global In Vivo Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Organoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Organoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Organoid Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 35. Global Bioprinting Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Bioprinting Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Bioprinting Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Computational Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Computational Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Computational Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Microscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Microscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Microscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Global Disease Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Disease Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Disease Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global COPD Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global COPD Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global COPD Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Fibrosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Fibrosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Fibrosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Precision Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Precision Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Precision Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Toxicity Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Toxicity Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Toxicity Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Human Lung Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Human Lung Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. North America Human Lung Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. North America Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 106. North America Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 107. North America Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 108. North America Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 109. North America Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 110. North America Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. North America Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 112. North America Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Latin America Human Lung Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Latin America Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 115. Latin America Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 116. Latin America Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 117. Latin America Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. Latin America Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 119. Latin America Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Latin America Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 121. Latin America Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Europe Human Lung Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Europe Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 124. Europe Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 125. Europe Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 126. Europe Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 127. Europe Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 128. Europe Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. Europe Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 130. Europe Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Middle East Human Lung Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Middle East Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 133. Middle East Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 134. Middle East Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 135. Middle East Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. Middle East Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 137. Middle East Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Middle East Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 139. Middle East Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Africa Human Lung Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Africa Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 142. Africa Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 143. Africa Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 144. Africa Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. Africa Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 146. Africa Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Africa Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 148. Africa Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Global Human Lung Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. ASEAN Human Lung Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. ASEAN Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 152. ASEAN Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 153. ASEAN Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 154. ASEAN Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 155. ASEAN Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 156. ASEAN Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. ASEAN Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 158. ASEAN Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. GCC Human Lung Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. GCC Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 161. GCC Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 162. GCC Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 163. GCC Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. GCC Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 165. GCC Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. GCC Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 167. GCC Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. European Union Human Lung Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. European Union Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 170. European Union Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 171. European Union Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 172. European Union Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. European Union Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 174. European Union Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. European Union Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 176. European Union Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. BRICS Human Lung Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. BRICS Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 179. BRICS Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 180. BRICS Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 181. BRICS Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 182. BRICS Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 183. BRICS Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. BRICS Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 185. BRICS Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. G7 Human Lung Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. G7 Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 188. G7 Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 189. G7 Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 190. G7 Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 191. G7 Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 192. G7 Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. G7 Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 194. G7 Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. NATO Human Lung Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. NATO Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 197. NATO Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 198. NATO Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 199. NATO Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. NATO Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 201. NATO Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. NATO Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 203. NATO Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Global Human Lung Models Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. United States Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 206. United States Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 207. United States Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 208. United States Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 209. United States Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. United States Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 211. United States Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. United States Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 213. United States Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Canada Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 215. Canada Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 216. Canada Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 217. Canada Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 218. Canada Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 219. Canada Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 220. Canada Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Canada Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 222. Canada Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Mexico Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 224. Mexico Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 225. Mexico Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 226. Mexico Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 227. Mexico Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. Mexico Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 229. Mexico Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Mexico Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 231. Mexico Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Brazil Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 233. Brazil Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 234. Brazil Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 235. Brazil Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 236. Brazil Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Brazil Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 238. Brazil Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Brazil Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 240. Brazil Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. United Kingdom Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 242. United Kingdom Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 243. United Kingdom Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 244. United Kingdom Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 245. United Kingdom Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. United Kingdom Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 247. United Kingdom Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. United Kingdom Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 249. United Kingdom Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Germany Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 251. Germany Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 252. Germany Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 253. Germany Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 254. Germany Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 255. Germany Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 256. Germany Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. Germany Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 258. Germany Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. France Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 260. France Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 261. France Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 262. France Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 263. France Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. France Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 265. France Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. France Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 267. France Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Russia Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 269. Russia Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 270. Russia Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 271. Russia Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 272. Russia Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 273. Russia Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 274. Russia Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Russia Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 276. Russia Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Italy Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 278. Italy Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 279. Italy Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 280. Italy Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 281. Italy Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 282. Italy Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 283. Italy Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. Italy Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 285. Italy Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Spain Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 287. Spain Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 288. Spain Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 289. Spain Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 290. Spain Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. Spain Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 292. Spain Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Spain Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 294. Spain Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. China Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 296. China Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 297. China Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 298. China Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 299. China Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 300. China Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 301. China Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. China Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 303. China Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. India Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 305. India Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 306. India Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 307. India Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 308. India Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. India Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 310. India Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. India Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 312. India Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Japan Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 314. Japan Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 315. Japan Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 316. Japan Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 317. Japan Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 318. Japan Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 319. Japan Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. Japan Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 321. Japan Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Australia Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 323. Australia Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 324. Australia Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 325. Australia Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 326. Australia Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 327. Australia Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 328. Australia Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. Australia Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 330. Australia Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. South Korea Human Lung Models Market Size, 2017-2032 (USD Million)
TABLE 332. South Korea Human Lung Models Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 333. South Korea Human Lung Models Market Size, by In Vitro, 2017-2032 (USD Million)
TABLE 334. South Korea Human Lung Models Market Size, by 3D Cultures, 2017-2032 (USD Million)
TABLE 335. South Korea Human Lung Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 336. South Korea Human Lung Models Market Size, by Imaging, 2017-2032 (USD Million)
TABLE 337. South Korea Human Lung Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 338. South Korea Human Lung Models Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 339. South Korea Human Lung Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. Global Human Lung Models Market Share, by Key Player, 2025
TABLE 341. Global Human Lung Models Market, Key Experts

Companies Mentioned

  • AlveoliX Sàrl
  • CN Bio Innovations Limited
  • Emulate, Inc.
  • Epithelix Sàrl
  • Hurel Corporation
  • InSphero AG
  • MatTek Corporation
  • MIMETAS B.V.
  • Nortis, Inc.
  • TissUse GmbH

Related Topics

Related Reports

Irreversible Electroporation Ablators Market - Global Forecast 2026-2032 - Product Image

Irreversible Electroporation Ablators Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Disposable Fully Automatic Biopsy Device Market - Global Forecast 2026-2032 - Product Image

Disposable Fully Automatic Biopsy Device Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Heart-Lung Machines - Global Strategic Business Report - Product Image

Heart-Lung Machines - Global Strategic Business Report

  • Report
  • 395 Pages
  • Global
From
Transcatheter Embolization and Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Transcatheter Embolization and Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.